RTTNews | Jan 4, 2022 10:43AM EST

10:43 Tuesday, January 4, 2022 (RTTNews.com) - The Denmark-based biotech company, Novo Nordisk A/S (NVO), is trading 4% lower in the market despite the company posting no corporate-related news to affect the stock. The stock continued to drop in the past 20 days, losing 10% since December 16, 2021. The stock is currently dealing at $104.77, down $4.02 or 3.70% since the previous close at $108.79. The stock opened at $103.87 in the morning. In the 52-week period, the stock has ranged between $66.59 and $117.35 per share. The company traditionally operates in two segments, Diabetes and Obesity care, and Biopharm. The company is also in collaboration with Lund University and Bluebird, Inc to develop treatments for Parkinson's disease and genetic editing of humans.

Read the original article on RTTNews ( https://www.rttnews.com/3252695/novo-drops-4-downtick-continues.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2022 RTTNews.com All Rights Reserved